SAPTALIS PHARMS FDA Approval ANDA 211309

ANDA 211309

SAPTALIS PHARMS

FDA Drug Application

Application #211309

Application Sponsors

ANDA 211309SAPTALIS PHARMS

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL500MG/5ML0METFORMIN HYDROCHLORIDEMETFORMIN HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-03-03STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAB

CDER Filings

SAPTALIS PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211309
            [companyName] => SAPTALIS PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"METFORMIN HYDROCHLORIDE","activeIngredients":"METFORMIN HYDROCHLORIDE","strength":"500MG\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/03\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-03-03
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.